204 related articles for article (PubMed ID: 32308555)
1. Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease.
Kluge KE; Langseth MS; Opstad TB; Pettersen AÅ; Arnesen H; Tønnessen T; Seljeflot I; Helseth R
Mediators Inflamm; 2020; 2020():5080743. PubMed ID: 32308555
[TBL] [Abstract][Full Text] [Related]
2. Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease.
Langseth MS; Opstad TB; Bratseth V; Solheim S; Arnesen H; Pettersen AÅ; Seljeflot I; Helseth R
Eur J Prev Cardiol; 2018 May; 25(7):762-769. PubMed ID: 29473463
[TBL] [Abstract][Full Text] [Related]
3. NETosis in Long-Term Type 1 Diabetes Mellitus and Its Link to Coronary Artery Disease.
Aukrust SG; Holte KB; Opstad TB; Seljeflot I; Berg TJ; Helseth R
Front Immunol; 2021; 12():799539. PubMed ID: 35069582
[TBL] [Abstract][Full Text] [Related]
4. Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study.
Helseth R; Knudsen EC; Eritsland J; Opstad TB; Arnesen H; Andersen GØ; Seljeflot I
BMC Cardiovasc Disord; 2019 Oct; 19(1):221. PubMed ID: 31615411
[TBL] [Abstract][Full Text] [Related]
5. Complement activation in association with clinical outcomes in ST-elevation myocardial infarction.
Kluge KE; Langseth MS; Andersen GØ; Halvorsen S; Opstad TB; Arnesen H; Tønnessen T; Seljeflot I; Helseth R
Am Heart J Plus; 2022 Dec; 24():100228. PubMed ID: 38560636
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI.
Helseth R; Shetelig C; Andersen GØ; Langseth MS; Limalanathan S; Opstad TB; Arnesen H; Hoffmann P; Eritsland J; Seljeflot I
Mediators Inflamm; 2019; 2019():7816491. PubMed ID: 31772506
[TBL] [Abstract][Full Text] [Related]
7. Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction.
Langseth MS; Helseth R; Ritschel V; Hansen CH; Andersen GØ; Eritsland J; Halvorsen S; Fagerland MW; Solheim S; Arnesen H; Seljeflot I; Opstad TB
Sci Rep; 2020 Mar; 10(1):5007. PubMed ID: 32193509
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil extracellular traps-associated markers are elevated in patients with systemic lupus erythematosus.
Jeremic I; Djuric O; Nikolic M; Vlajnic M; Nikolic A; Radojkovic D; Bonaci-Nikolic B
Rheumatol Int; 2019 Nov; 39(11):1849-1857. PubMed ID: 31444555
[TBL] [Abstract][Full Text] [Related]
9. IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.
Orrem HL; Nilsson PH; Pischke SE; Kleveland O; Yndestad A; Ekholt K; Damås JK; Espevik T; Bendz B; Halvorsen B; Gregersen I; Wiseth R; Andersen GØ; Ueland T; Gullestad L; Aukrust P; Barratt-Due A; Mollnes TE
Front Immunol; 2018; 9():2035. PubMed ID: 30258440
[No Abstract] [Full Text] [Related]
10. The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris.
Helseth R; Solheim S; Arnesen H; Seljeflot I; Opstad TB
Mediators Inflamm; 2016; 2016():2182358. PubMed ID: 28074081
[No Abstract] [Full Text] [Related]
11. Neutrophil extracellular traps and dsDNA predict outcomes among patients with ST-elevation myocardial infarction.
Liu J; Yang D; Wang X; Zhu Z; Wang T; Ma A; Liu P
Sci Rep; 2019 Aug; 9(1):11599. PubMed ID: 31406121
[TBL] [Abstract][Full Text] [Related]
12. Circulating Myeloperoxidase (MPO)-DNA complexes as marker for Neutrophil Extracellular Traps (NETs) levels and the association with cardiovascular risk factors in the general population.
Donkel SJ; Wolters FJ; Ikram MA; de Maat MPM
PLoS One; 2021; 16(8):e0253698. PubMed ID: 34379628
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure.
Langseth MS; Andersen GØ; Husebye T; Arnesen H; Zucknick M; Solheim S; Eritsland J; Seljeflot I; Opstad TB; Helseth R
PLoS One; 2020; 15(10):e0241333. PubMed ID: 33119664
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil activation and neutrophil derived neutrophil extracellular trap formation in patients with coronary artery ectasia.
Guo Y; Liu R; Chen L; Wu W; Zhang S
BMC Cardiovasc Disord; 2020 Mar; 20(1):101. PubMed ID: 32122307
[TBL] [Abstract][Full Text] [Related]
15. C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps.
Silva BM; Gomes GF; Veras FP; Cambier S; Silva GV; Quadros AU; Caetité DB; Nascimento DC; Silva CM; Silva JC; Damasceno S; Schneider AH; Beretta F; Batah SS; Castro IM; Paiva IM; Rodrigues T; Salina A; Martins R; Cebinelli GC; Bibo NL; Jorge DM; Nakaya HI; Zamboni DS; Leiria LO; Fabro AT; Alves-Filho JC; Arruda E; Louzada-Junior P; Oliveira RD; Cunha LD; Van Mol P; Vanderbeke L; Feys S; Wauters E; Brandolini L; Aramini A; Cunha FQ; Köhl J; Allegretti M; Lambrechts D; Wauters J; Proost P; Cunha TM
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37104043
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil extracellular traps (NETs) in cardiovascular diseases: From molecular mechanisms to therapeutic interventions.
Natorska J; Ząbczyk M; Undas A
Kardiol Pol; 2023; 81(12):1205-1216. PubMed ID: 38189504
[TBL] [Abstract][Full Text] [Related]
17. Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).
Rathnayake N; Gustafsson A; Norhammar A; Kjellström B; Klinge B; Rydén L; Tervahartiala T; Sorsa T;
PLoS One; 2015; 10(7):e0126370. PubMed ID: 26132583
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia.
Mikacenic C; Moore R; Dmyterko V; West TE; Altemeier WA; Liles WC; Lood C
Crit Care; 2018 Dec; 22(1):358. PubMed ID: 30587204
[TBL] [Abstract][Full Text] [Related]
19. Silenced-C5ar1 improved multiple organ injury in sepsis rats via inhibiting neutrophil extracellular trap.
Shen B; Shen Q; Zeng Q; Zhang L; Li X
J Mol Histol; 2024 Feb; 55(1):69-81. PubMed ID: 38165570
[TBL] [Abstract][Full Text] [Related]
20. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
